[1]
2025. Comparative Effectiveness of Statins Vs PCSK9 Inhibitors in High-Risk CV patients. Indus Journal of Bioscience Research. 3, 4 (Apr. 2025), 777–781. DOI:https://doi.org/10.70749/ijbr.v3i4.1238.